Breaking News

Novozymes Sales Rise 7% in 2012

April 4, 2013

• Novozymes’s 2012 sales rose 7% to more than $2.0 billion, the company reported. Net profit rose 10% to nearly $360 million. This year, the company expects organic sales growth of 5-8%.

“We delivered strong earnings growth and record profitability in a year when organic sales growth was challenged and came in at 4%—below our ambition,” said Steen Riisgaard, president and CEO. “With 2012 behind us, we have reviewed our long-term growth scenarios and decided to adjust our long-term financial targets. We are still confident that we can reach the long-term sales growth target of more than 10%, although not until 2015.”

Riisgaard reiterated that the company’s strategy is unchanged and, under the leadership of the new president and CEO Peder Holk Nielsen, Novozymes will continue to focus on innovation, partnerships and sustainability.

blog comments powered by Disqus
  • Electric Slide

    Electric Slide

    Melissa Meisel, Associate Editor||February 3, 2016
    Skin care devices bring anti-aging to the next level

  • Crowning Glory

    Crowning Glory

    Christine Esposito , Associate Editor||February 3, 2016
    Celebrity stylists and experts from leading hair care brands talk about the ingredients and formats driving the styling sector.

  • Innovation On Display

    Melissa Meisel, Associate Editor||February 3, 2016
    P&G Beauty Digital Studio showcases new products for 2016